Mark A. Goldsmith, See Remarks at Revolution Medicines, Inc. (RVMD), sold 26,822 shares at $45.82 ($1.2M) on 2025-09-16, disclosed to the SEC on 2025-09-18.
Scheduled sale ($1.2M) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.82 | 13,411 | $614K | 50.0% |
| 2 | $45.82 | 13,411 | $614K | 50.0% |
| Total | $45.82 avg | 26,822 | $1.2M | 100% |
| Filing → |
| RVMD | SELL | 2026-06-18 | $1.6M | — | Filing → |
| RVMD | SELL | 2026-04-17 | $18.0M | — | Filing → |
| RVMD | SELL | 2026-03-19 | $2.6M | — | Filing → |